Increased Serum Leptin Levels and Over Expression of Leptin Receptors are Associated With the Invasion and Progression of Renal Cell Carcinoma

Journal of Urology

Volumn 176, Issue 4, 2006, Pages 1631-1635

  Horiguchi, Akio ^a,b   Sumitomo, Makoto ^a   Asakuma, Junichi ^a   Asano, Takako ^a   Zheng, Rong ^b   Asano, Tomohiko ^a   Nanus, David M ^b   Hayakawa, Masamichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

carcinoma; kidney; leptin; neoplasm invasiveness; obesity; renal cell

Indexed keywords

LEPTIN; LEPTIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; VASCULAR TUMOR;

ADULT; AGED; BODY MASS INDEX; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LEPTIN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, CELL SURFACE; TREATMENT OUTCOME;

EID: 33748098353     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.06.039     Document Type: Article

References (20)

1. Weigle D.S., Bukowski T.R., Foster D.C., Holderman S., Kramer J.M., Lasser G., et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 96 (1995) 2065
2. Fantuzzi G., and Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68 (2000) 437
3. Sierra-Honigmann M.R., Nath A.K., Murakami C., Garcia-Cardena G., Papapetropoulos A., Sessa W.C., et al. Biological action of leptin as an angiogenic factor. Science 281 (1998) 1683
4. Goetze S., Bungenstock A., Czupalla C., Eilers F., Stawowy P., Kintscher U., et al. Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. Hypertension 40 (2002) 748
5. Hu X., Juneja S.C., Maihle N.J., and Cleary M.P. Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94 (2002) 1704
6. Laud K., Gourdou I., Pessemesse L., Peyrat J.P., and Djiane J. Identification of leptin receptors in human breast cancer. functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188 (2002) 219
7. Dieudonne M.N., Machinal-Quelin F., Serazin-Leroy V., Leneveu M.C., Pecquery R., and Giudicelli Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 293 (2002) 622
8. Stattin P., Soderberg S., Hallmans G., Bylund A., Kaaks R., Stenman U.H., et al. Leptin is associated with increased prostate cancer risk. a nested case-referent study. J Clin Endocrinol Metab 86 (2001) 1341
9. Tessitore L., Vizio B., Pesola D., Cecchini F., Mussa A., Argiles J.M., et al. Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol 24 (2004) 1529
10. Stattin P., Lukanova A., Biessy C., Soderberg S., Palmqvist R., Kaaks R., et al. Obesity and colon cancer. does leptin provide a link?. Int J Cancer 109 (2004) 149
11. Ishikawa M., Kitayama J., and Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10 (2004) 4325
12. Tourani J.M., Pfister C., Tubiana N., Ouldkaci M., Prevot G., Lucas V., et al., Subcutaneous Administration Propeukin Program Cooperative Group. Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma. final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design. J Clin Oncol 21 (2003) 3987
13. Yu M.C., and Ross R.K. Obesity, hypertension, and renal cancer. N Engl J Med 344 (2001) 531
14. Moyad M.A. Obesity, interrelated mechanisms, and exposures and kidney cancer. Semin Urol Oncol 19 (2001) 270
15. Horiguchi A., Oya M., Shimada T., Uchida A., Marumo K., and Murai M. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma. a study of incidence and its association with pathological features and clinical outcome. J Urol 168 (2002) 762
16. Saglam K., Aydur E., Yilmaz M., and Goktas S. Leptin influences cellular differentiation and progression in prostate cancer. J Urol 169 (2003) 1308
17. Rasmuson T., Grankvist K., Jacobsen J., Olsson T., and Ljungberg B. Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncol 43 (2004) 744
18. Oelmann E., Haghgu S., Kulimova E., Serve H., Schmitmann C., and Berdel W.E. Re. leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 95 (2003) 1171
19. Attoub S., Noe V., Pirola L., Bruyneel E., Chastre E., Mareel M., et al. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. Faseb J 14 (2000) 2329
20. Hotakainen K., Ljungberg B., Haglund C., Nordling S., Paju A., and Stenman U.H. Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma. prognostic study on tissue and serum. Int J Cancer 104 (2003) 631